The role of trifluridine/tipiracil in pretreated mCRC patients
15. 03. 2017
07:15
-
07:15
Lokacija: predavalnica stavbe C
Predavatelj: Prof. Gerald Prager, MD (Associate Professor of Medicine, Head of the Intestinal-Cancer Program Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna)